Ethiopia Medical Device Registration Basics: Three Certificates, One Sequence

1. Key takeaways

Lawful placement of a medical device on the Ethiopian market requires three certificates, obtained in sequence, and none of them can be skipped: the Certificate of Competence (CoC) proves that the establishment has the premises, personnel and facilities required to trade in devices; the Marketing Authorization (MA) proves that the specific product has passed technical review; and the Import Permit is the precondition for the goods to actually clear customs. The three certificates map onto three modules of the electronic regulatory information system (eRIS) — i-License, i-Register and i-Import — and the order cannot be reversed. The most common mistake made by manufacturers from the Chinese mainland and other overseas markets is to pour all their effort into the product dossier while overlooking the fact that the CoC is a precondition for the agency agreement to take effect. When the local agent has no CoC, the agency agreement is not accepted, and every downstream application becomes impossible to submit. Companies should therefore plan the entire timeline backwards, from the import permit through the MA and the agency agreement to the CoC, and treat the CoC as the true first step of any Ethiopian registration project rather than a parallel administrative formality.

2. Legal basis

3. Expert insights

Insight 1: the three certificates answer three different legal questions. The CoC answers who is qualified to trade in devices; the MA answers whether this particular product may be sold; the import permit answers whether this particular consignment can enter the country. They are issued by different bodies through different processes: the CoC is granted by the inspection and licensing directorate after on-site verification of the establishment, the MA is granted by the product registration and licensing directorate after dossier review, and the import permit is generated by i-Import on the basis of a valid MA. Understanding the scheme as a single application that yields three certificates at once is a fundamental misjudgment, and it leads directly to rejected submissions and wasted lead time.

Insight 2: the CoC is a precondition of the agency agreement, not a parallel item. Section 9.2.3(h) of the general guideline requires explicitly that an agent handling import on behalf of a manufacturer must hold, at the time of import, a trade licence issued by the Ministry of Trade as well as a Certificate of Competence issued by EFDA. This means that if the local agent has not yet obtained the CoC, the chain of applications is broken at the very first step, even where the agency agreement has already been signed and the USD 50 agreement fee has been paid. Sequencing errors at this point are not recoverable by submitting the MA application faster.

Insight 3: ownership and custody of the MA certificate are deliberately split. Section 11.3 of the general guideline provides that the marketing authorization certificate is granted to the license holder, but it is transmitted through the local agent or representative, and the agent must immediately deliver the certificate to the license holder. In practice, an overseas manufacturer is the legal right-holder, yet the certificate first passes through the hands of the local agent. Selecting an agent is therefore not merely a commercial decision but a question of control over the registration documents that the business depends on.

Insight 4: automatic generation of the import permit lowers procedural cost, but only while the MA remains valid. i-Import generates the import permit certificate on the basis of a valid marketing authorization, and port inspectors can verify it online. Once the MA expires or is withdrawn, the import permit can no longer be generated, and the risk of goods being stranded at port rests entirely on the license holder. This differs sharply from jurisdictions that allow clearance first and documentary repair afterwards; in Ethiopia there is no procedural cushion to absorb an lapsed authorization.

Insight 5: the three certificates run on independent clocks and must be maintained separately. The CoC has its own renewal cycle, the MA is valid for five years, and the import permit is issued per consignment. Because the three timelines are not synchronized, a company that maintains a single expiry-reminder table will inevitably miss two of the three deadlines. Distinct ledgers, distinct owners and distinct renewal triggers are the minimum control framework for the Ethiopian market.

4. Practical recommendations

1. Plan backwards along the sequence CoC → agency agreement → MA → import permit, and start by confirming that the local agent already holds a valid CoC.
2. State the certificate delivery deadline in the agency agreement, invoking the immediate-delivery requirement of Section 11.3.
3. Maintain three separate expiry ledgers for the CoC, the MA and the import permit; do not merge them into one tracker.
4. Start re-registration at least three months before MA expiry to avoid breaking the import permit chain.
5. Check all three certificates whenever a change occurs, since a change of agent affects the entity information on both the CoC and the MA.
6. Retain every payment receipt; each certificate carries its own fee, and receipts must be traceable to the application number.

5. Verification checklist

• □ Confirmed that the local agent holds a valid Certificate of Competence (CoC)
• □ Confirmed that the marketing authorization (MA) for the products to be imported is within its validity period
• □ Created applicant accounts and access rights in each of the three eRIS modules
• □ Established independent ledgers for expiry and changes of all three certificates
• □ Agreed in the agency contract on a delivery deadline and liability for the marketing authorization certificate

Regulatory information verified as of October 29, 2026. The article numbers, module names and sequencing set out above are based on the official documents published by the Ethiopian Food and Drug Authority (EFDA) currently in force; where guideline versions are updated or system modules are adjusted, the information must be re-checked.

• Ethiopia local support: GRZAN assists manufacturers from the Chinese mainland and overseas in dealing with the Ethiopian Food and Drug Authority (EFDA) on marketing authorization (MA), Certificate of Competence (CoC) and import permit applications, including local agent planning and agency agreement review, SRA reliance pathway justification, UMDN coding and classification determination, technical dossier preparation, and the setup of vigilance and post-market surveillance systems.
• Service capabilities: product attribute determination and risk classification (non-IVD Class I–IV / IVD Class A–D), marketing authorization applications and re-registration, low-risk notification eligibility assessment, Essential Principles conformity justification, labelling and instructions-for-use localization in English, and support for vigilance reports and field safety corrective actions.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.